CD274 and cancer: KEGG enrichment results showed that these targets were mainly enriched in the PI3K-Akt signaling pathway, T-cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint expression in cancer, and the HIF-1 signaling pathway (Figure 5E).